GNTA logo

Genenta Science SpA (GNTA) Financials

Balance sheets

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202231 Dec 202130 June 202131 Dec 2020

Total Assets

$20.4 M(-17.5%)$24.7 M(-14.9%)$29.0 M(-19.0%)$35.9 M(-10.3%)$40.0 M(-11.8%)$45.3 M(+186.5%)$15.8 M(-26.5%)$21.5 M

Current Assets

$19.9 M(-15.3%)$23.5 M(-11.8%)$26.6 M(-21.7%)$34.0 M(-12.9%)$39.1 M(-11.0%)$43.9 M(+204.7%)$14.4 M(-29.2%)$20.3 M

Non Current Assets

$479.9 K(-60.2%)$1.2 M(-49.8%)$2.4 M(+30.5%)$1.8 M(+102.7%)$908.0 K(-36.7%)$1.4 M(+1.6%)$1.4 M(+18.7%)$1.2 M

Total Liabilities

$2.4 M(+11.4%)$2.1 M(+1.3%)$2.1 M(-15.3%)$2.5 M(+83.2%)$1.3 M(+2.0%)$1.3 M(-34.4%)$2.0 M(-30.4%)$2.9 M

Current Liabilities

$2.1 M(+11.5%)$1.9 M(-0.3%)$1.9 M(-17.8%)$2.3 M(+86.6%)$1.3 M(-2.4%)$1.3 M(-35.3%)$2.0 M(-30.8%)$2.9 M

Long Term Liabilities

$219.0 K(+10.6%)$198.1 K(+21.2%)$163.5 K(+31.2%)$124.6 K(+36.2%)$91.5 K(+163.7%)$34.7 K(+34.5%)$25.8 K(+20.6%)$21.4 K

Shareholders Equity

$18.0 M(-20.2%)$22.6 M(-16.2%)$27.0 M(-19.3%)$33.4 M(-13.6%)$38.6 M(-12.2%)$44.0 M(+218.7%)$13.8 M(-25.9%)$18.6 M

Book Value

$18.0 M(-20.2%)$22.6 M(-16.2%)$27.0 M(-19.3%)$33.4 M(-13.6%)$38.6 M(-12.2%)$44.0 M(+218.7%)$13.8 M(-25.9%)$18.6 M

Working Capital

$17.8 M(-17.7%)$21.6 M(-12.7%)$24.7 M(-22.0%)$31.7 M(-16.3%)$37.8 M(-11.2%)$42.6 M(+243.0%)$12.4 M(-28.9%)$17.5 M

Cash And Cash Equivalents

$6.6 M(+62.5%)$4.1 M(-69.3%)$13.3 M(-58.5%)$32.0 M(-11.8%)$36.2 M(-14.1%)$42.2 M(+235.7%)$12.6 M(-34.0%)$19.0 M

Accounts Payable

$435.0 K(+33.4%)$326.1 K(-14.1%)$379.6 K(-66.0%)$1.1 M(+331.5%)$259.0 K(+38.8%)$186.6 K(-42.1%)$322.4 K(-51.9%)$670.3 K

Accounts Receivable

--------

Short Term Debt

--------

Long Term Debt

--------

Total Debt

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0

Current Ratio

9.3(-24.1%)12.3(-11.5%)13.8(-4.8%)14.5(-53.4%)31.1(-8.8%)34.1(+370.4%)7.3(+2.4%)7.1

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$54.9 M(-5.3%)-$52.1 M(-13.6%)-$45.9 M(-20.6%)-$38.0 M(-25.0%)-$30.4 M(+0.5%)-$30.6 M(-0.7%)-$30.4 M(-15.0%)-$26.4 M

PB Ratio

3.1(-21.1%)4.0(+0.3%)4.0(+32.7%)3.0(-9.4%)3.3(-27.1%)4.5--

Income statements

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202231 Dec 202130 June 202131 Dec 2020

EPS

--------

TTM EPS

--------

Revenue

--------

TTM Revenue

--------

Total Expenses

--------

Operating Expenses

--------

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

--------

TTM Operating Profit

--------

Operating Margin

--------

Net Income

--------

TTM Net Income

--------

Net Margin

--------

EBIT

--------

TTM EBIT

--------

EBITDA

--------

TTM EBITDA

--------

Selling, General & Administrative Expenses

--------

TTM SG&A

--------

Depreciation And Amortization

--------

TTM D&A

--------

Interest Expense

--------

TTM Interest Expense

--------

Income Tax

--------

TTM Income Tax

--------

PE Ratio

--------

PS Ratio

--------

Cashflow statements

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202231 Dec 202130 June 202131 Dec 2020

Cash From Operations

--------

TTM CFO

--------

Cash From Investing

--------

TTM CFI

--------

Cash From Financing

--------

TTM CFF

--------

Free Cash Flow

--------

TTM FCF

--------

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------